Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 5/20 | 0.63 |
| ▸ | ACHE | P22303 | 5/20 | 0.51 |
| ▸ | CTSL | P07711 | 4/20 | 0.45 |
| ▸ | CTSB | P07858 | 4/20 | 0.45 |
| ▸ | BCHE | P06276 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL606630 | 1.00 | PTGS2 (0.63) | PTGS2ACHECTSLCTSBBCHE | |
| SCHEMBL606631 | 1.00 | PTGS2 (0.63) | PTGS2ACHECTSLCTSBBCHE | |
| SCHEMBL10061385 | 0.99 | PTGS2 (0.62) | PTGS2ACHECTSLCTSBBCHE | |
| SCHEMBL610240 | 0.99 | PTGS2 (0.62) | PTGS2ACHECTSLCTSBBCHE | |
| SCHEMBL610239 | 0.99 | PTGS2 (0.62) | PTGS2ACHECTSLCTSBBCHE | |
| SCHEMBL10061396 | 0.92 | PTGS2 (0.54) | PTGS2ACHEMAPTFGFR1 | |
| SCHEMBL608843 | 0.92 | PTGS2 (0.54) | PTGS2ACHEMAPTFGFR1 | |
| SCHEMBL608844 | 0.92 | PTGS2 (0.54) | PTGS2ACHEMAPTFGFR1 | |
| SCHEMBL610609 | 0.84 | CYP2C9 (0.50) | PTGS2ACHEMAPT | |
| SCHEMBL610608 | 0.84 | CYP2C9 (0.50) | PTGS2ACHEMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120040976-A1 | SMALL MOLECULE IMMUNOMODULATORS FOR ALZHEIMER'S DISEASE | HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) | 2012-02-16 | — | — | US | disclosed |
| US-20120040976-A1 | SMALL MOLECULE IMMUNOMODULATORS FOR ALZHEIMER'S DISEASE | HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) | 2012-02-16 | — | — | US | disclosed |
| WO-2010068935-A2 | SMALL MOLECULE IMMUNOMODULATORS FOR ALZHEIMER'S DISEASE | HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) | 2010-06-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120040976-A1 | SMALL MOLECULE IMMUNOMODULATORS FOR ALZHEIMER'S DISEASE | L1CAM, LY96, GMFG | PTGS2 1859/4885ACHE 18/4885CTSL 735/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.